S100A9 and psoriasis: After complement components and immunoglobulin chains, S100A8 was the first protein that, as an alarmin, plays a key role in the development of inflammation; moreover, it has been suggested that S100/S100A9 heterodimer may represent a good therapeutic target in psoriasis and psoriatic arthritis (36).